Long-Term Effect and Safety of Tocilizumab on Severe Adult-Onset Still’s Disease Accompanied by Thrombotic Thrombocytopenic Purpura
Main Article Content
Abstract
Cite this article as: Suwabe T, Yamanouchi M, Ubara Y, Sawa N. Long-term effect and safety of tocilizumab on severe adult-onset Still’s disease accompanied by thrombotic thrombocytopenic purpura. Eur J Rheumatol. 2025, 12(4), 0029, doi: 10.5152/eurjrheum.2025.25029.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.